Vimarsana
Biggest News Aggregation in the World

Page 7 - Board Certification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Board Certification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Board Certification Today - Breaking & Trending Today

Severity of TRD Predicts Ketamine vs ECT Response - Vimarsana News

Severity of TRD Predicts Ketamine vs ECT Response

The severity of TRD appeared to predict response to IV ketamine vs ECT. However, experts said more research is needed before drawing any definitive conclusions.

Does AD Severity Affect Growth in Children? - Vimarsana News

Does AD Severity Affect Growth in Children?

An analysis evaluated growth in a study of 1326 children with AD younger than 12 years.

Neuromodulators: Rapid-Onset Option, Other Emerging Trends - Vimarsana News

Neuromodulators: Rapid-Onset Option, Other Emerging Trends

Expect intradermal injections of botulinum toxin A for the improvement in the appearance of pores, sebum, skin texture, and rosacea to gain a foothold in dermatology practices, one expert says.

Infliximab and Biosimilar Yield Similar Results in IBD - Vimarsana News

Infliximab and Biosimilar Yield Similar Results in IBD

New data supported the safety and efficacy of nonmedical switching from infliximab to a biosimilar, according to researchers.

Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study - Vimarsana News

Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study

Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.